Guardant Health Revenue and Competitors

Claim your profile

Location

$550M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Guardant Health's estimated annual revenue is currently $343.9M per year.(i)
  • Guardant Health received $360.0M in venture funding in May 2017.
  • Guardant Health's estimated revenue per employee is $132,254
  • Guardant Health's total funding is $550M.
  • Guardant Health's current valuation is $7.9B. (January 2022)

Employee Data

  • Guardant Health has 2600 Employees.(i)
  • Guardant Health grew their employee count by 53% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4280M123836%$28M$63.3B
#2
$564.8M374927%$404.1M$6.4B
#3
$454.5M732230%$1BN/A
#4
$300.8M121334%$2B$2.5B
#5
$434.8M353827%$2B$2.7B

We believe conquering cancer is a big data problem. That's why we built the world's leading comprehensive liquid biopsy. This non-invasive tool for accessing and sequencing tumor DNA is used by thousands of oncologists to help tens of thousands of advanced cancer patients. We believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. We're working on some exciting ones, including in early detection, where the impact on patients can be profound. We've raised more than $500 million from investors including Sequoia Capital, Khosla Ventures, OrbiMed, and SoftBank.

keywords:Biotechnology,Enterprise Software,Health It,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals

$550M

Total Funding

2600

Number of Employees

$343.9M

Revenue (est)

53%

Employee Growth %

$7.9B

Valuation

N/A

Accelerator

Guardant Health News

2022-04-20 - With milestones on the horizon, Guardant Health CEOs lay out ...

SAN DIEGO — Bay Area biotech Guardant Health is closer than ever to its ultimate goal — developing and deploying a simple, blood-based test...

2022-04-20 - Where Does Wall Street Think Guardant Health Inc (GH) Stock Will Go?

That average ranking earns Guardant Health Inc an Analyst Rating of 68, which is better than 68% of stocks based on data compiled by...

2022-04-20 - With milestones on the horizon, Guardant Health CEOs lay out ...

SAN DIEGO — Bay Area biotech Guardant Health is closer than ever to its ultimate goal — developing and deploying a simple, blood-based test...

2022-04-20 - Where Does Wall Street Think Guardant Health Inc (GH) Stock Will Go?

That average ranking earns Guardant Health Inc an Analyst Rating of 68, which is better than 68% of stocks based on data compiled by...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$542.9M271233%$477.4M
#2
$300M33547%N/A
#3
$839.9M3669-11%$1.1B
#4
$1158.9M570912%N/A
#5
$1410M5880N/AN/A

Guardant Health Funding

DateAmountRoundLead InvestorsReference
2014-02-12$10.0MUndisclosedSequoia CapitalArticle
2014-04-23$30.0MBKhosla VenturesArticle
2015-02-04$50.0MCLightspeed Venture PartnersArticle
2016-01-08$100.0MDOrbiMedArticle
2017-05-12$360.0MESoftBank GroupArticle